bioRxivCancer Biology
Stromal architecture directs early dissemination in pancreatic ductal adenocarcinoma
A. Ray, M. Callaway, N. Rodriguez-Merced, A. Crampton, M. Carlson, K. Emme, E. Ensminger, A. Kinne, J. Schrope, H. Rasmussen, H. Jiang, D. DeNardo, D. Wood, P. Provenzano
Abstract
Pancreatic ductal adenocarcinoma (PDA) is an extremely metastatic and lethal disease. Here in both murine and human PDA we demonstrate that extracellular matrix architecture regulates cell extrusion and subsequent invasion from intact ductal structures through Tumor-Associated Collagen Signatures (TACS), resulting in early dissemination from histologically pre-malignant lesions and continual invasion from well-differentiated disease. Furthermore, we show that pancreatitis results in invasion-conducive architectures, thus priming the stroma prior to malignant disease. Analysis in novel microfluidics-derived microtissues and in vivo demonstrates decreased extrusion and invasion following focal adhesion kinase (FAK) inhibition, consistent with decreased metastasis. Thus, data suggest that targeting FAK or strategies to re-engineer and normalize tumor microenvironments, may have a role not only in also in very early disease but also for limiting continued dissemination from unresectable disease. Likewise, it may be beneficial to employ stroma targeting strategies to resolve precursor diseases such as pancreatitis in order to remove stromal architectures that increase risk for early dissemination. Impact StatementCollagen architectures in the tumor stroma facilitate dissemination of carcinoma cells from the earliest histologically "pre-malignant" lesions and continue to promote disease spread from well-differentiated PDA.
- organism: mouse
- organism: human
- research focus: cancer & tumor microenvironment
- research focus: cell signaling & trafficking
- research focus: development & morphogenesis
- approach: experimental assay
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Loss of p21-activated kinase 4 (PAK4) suppresses pancreatic tumor progression and metastasis through regulating E-cadherin
Kui‐Jin Kim, Cheng Hyun Lee, … Jin Won Kim·Cancer Gene TherapyPeer-reviewed·Oct 31, 2026
- Pancreatic cancer cells breach endothelial barriers through protrusion-driven invasion or endothelial retraction
Gautier Follain, Sujan Ghimire, … Guillaume Jacquemet·bioRxiv·Sep 3, 2026
- DDR1-INDUCED NEUTROPHIL EXTRACELLULAR TRAPS DRIVE PANCREATIC CANCER METASTASIS
J. Deng, Y. Kang, … J. B. Fleming·bioRxiv·Aug 5, 2020
- Periductal Fibroblast Density Defines Lymphocyte Exclusion via a CD44-Dependent Stromal Checkpoint in Pancreatic Cancer
Zoe X. Malchiodi, Alexander A. Lekan, … Louis M. Weiner·Cancer Immunology ResearchPeer-reviewed·Jul 24, 2026
- TGF-β- and IL-1-dependent fibroblast states differentially shape pancreatic cancer microenvironments and metastasis
Priscilla S.W. Cheng, Eloise G. Lloyd, … Giulia Biffi·bioRxiv·Sep 10, 2026
- Targeting FGFR4 Abrogates HNF1A-driven Metastasis in Pancreatic Ductal Adenocarcinoma
Katherine J. Crawford, Kennedy S. Humphrey, … Ethan V. Abel·Molecular CancerPeer-reviewed·Jul 29, 2025